Rock Creek Group’s Labcorp LH Stock Holding History

Rock Creek Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14	Closed	-$2.75K	–	194
2023 Q1	$2.75K	Buy	+14	New	+$2.88K	﹤0.01%	178
2021 Q4	–	Sell	-20	Closed	-$5K	–	223
2021 Q3	$5K	Buy	+20	New	+$5.04K	﹤0.01%	174

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Rock Creek Group's LH Position: Q2 2023 in Review

Rock Creek Group sold out of Labcorp (LH) in Q2 2023, closing a stake of 14 shares — an estimated $2.75K sold.

Rock Creek Group first reported a position in LH in Q3 2021 and held it in 2 quarters. The position peaked at $5K in Q3 2021. 932 funds tracked by Wall St. Rank hold LH as of Q2 2023.

Rock Creek Group reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
Rock Creek Group sold 14 Labcorp shares in Q2 2023, an estimated $2.75K.
Rock Creek Group first reported a position in Labcorp in Q3 2021 and held it in 2 quarters.
Rock Creek Group's Labcorp position peaked at $5K in Q3 2021.
932 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on Rock Creek Group's 13F filing for Q2 2023, filed 9 Aug 2023.